Yonghong Li

1.0k total citations
65 papers, 691 citations indexed

About

Yonghong Li is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yonghong Li has authored 65 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 18 papers in Oncology. Recurrent topics in Yonghong Li's work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Yonghong Li is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Yonghong Li collaborates with scholars based in China, United States and Hong Kong. Yonghong Li's co-authors include Fangjian Zhou, Zhiling Zhang, Hui Han, Lijuan Jiang, Ahmed Elshafei, J. Stephen Jones, Zhuowei Liu, Zike Qin, Chunping Yu and Kai Yao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yonghong Li

58 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghong Li China 15 283 271 187 161 108 65 691
Milan Vošmik Czechia 17 254 0.9× 294 1.1× 258 1.4× 147 0.9× 57 0.5× 81 771
Priya Kumar India 14 193 0.7× 201 0.7× 204 1.1× 118 0.7× 152 1.4× 62 781
Mariana M. Cajaiba United States 16 328 1.2× 257 0.9× 155 0.8× 470 2.9× 62 0.6× 43 923
Isabel Trias Spain 15 337 1.2× 356 1.3× 177 0.9× 195 1.2× 98 0.9× 46 747
Andrea Ambrosini‐Spaltro Italy 14 194 0.7× 207 0.8× 224 1.2× 85 0.5× 110 1.0× 33 547
Markus Falk Germany 15 208 0.7× 364 1.3× 232 1.2× 140 0.9× 33 0.3× 58 803
H Sugao Japan 13 259 0.9× 193 0.7× 98 0.5× 94 0.6× 123 1.1× 56 526
Riley E. Alexander United States 14 180 0.6× 269 1.0× 168 0.9× 142 0.9× 26 0.2× 19 573
Giada Maria Vecchio Italy 18 199 0.7× 106 0.4× 135 0.7× 184 1.1× 258 2.4× 51 729
T. Geldart United Kingdom 15 178 0.6× 211 0.8× 293 1.6× 202 1.3× 43 0.4× 40 642

Countries citing papers authored by Yonghong Li

Since Specialization
Citations

This map shows the geographic impact of Yonghong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghong Li more than expected).

Fields of papers citing papers by Yonghong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghong Li. The network helps show where Yonghong Li may publish in the future.

Co-authorship network of co-authors of Yonghong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghong Li. A scholar is included among the top collaborators of Yonghong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghong Li. Yonghong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Anqi, Yuanwei Li, Yuanwei Li, et al.. (2024). Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors. SHILAP Revista de lepidopterología. 4(3). 280–287. 5 indexed citations
3.
Li, Yonghong, Wei Li, Yirui Liu, et al.. (2024). Efficacy and safety of anlotinib combined with vinorelbine as second‑line treatment for elderly patients with advanced squamous cell lung carcinoma: A retrospective cohort. Molecular and Clinical Oncology. 22(2). 21–21. 1 indexed citations
4.
Yang, Weitao, Tianjiao Liang, Yonghong Li, et al.. (2024). Neutron induced single event effects on near-memory computing architecture AI chips. Acta Physica Sinica. 73(13). 138502–138502.
5.
Kang, Ning, Zhaohui Zhou, Xingbo Long, et al.. (2023). Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling. Cancer Research. 83(22). 3753–3766. 8 indexed citations
6.
7.
Yu, Wei, Hao Zeng, Yonghong Li, et al.. (2022). Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients. Cancer Immunology Immunotherapy. 72(6). 1541–1551. 11 indexed citations
8.
Ni, Yuchao, Jinge Zhao, Yijun Zhang, et al.. (2021). Predictors of efficacy of corticosteroid switching from abiraterone plus prednisone to dexamethasone in patients with metastatic castration-resistant prostate cancer. Asian Journal of Andrology. 24(2). 154–160. 2 indexed citations
9.
Liu, Yang, Zitong Zhang, Sijuan Huang, et al.. (2021). Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience. Radiation Oncology. 16(1). 5–5. 2 indexed citations
10.
Zhu, Yao, Wei Yu, Hao Zeng, et al.. (2021). Inherited Mutations in Chinese Men With Prostate Cancer. Journal of the National Comprehensive Cancer Network. 20(1). 54–62. 17 indexed citations
11.
12.
Yu, Chunping, Zhuowei Liu, Qiuhong Chen, et al.. (2018). Nkx2.8 Inhibits Epithelial–Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of Twist1. Cancer Research. 78(5). 1241–1252. 13 indexed citations
13.
Li, Zhiyong, Shengjie Guo, Zhiming Wu, et al.. (2017). Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification. Urologic Oncology Seminars and Original Investigations. 35(9). 543.e1–543.e6. 9 indexed citations
14.
Chen, Mingkun, Yunlin Ye, Baojia Zou, et al.. (2016). C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation. Journal of Translational Medicine. 14(1). 55–55. 10 indexed citations
15.
Liu, Jianye, Yingbo Dai, Fangjian Zhou, et al.. (2016). The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy. Urologic Oncology Seminars and Original Investigations. 34(11). 484.e1–484.e8. 69 indexed citations
16.
Li, Yonghong, Ahmed Elshafei, Jianbo Li, et al.. (2014). Potential Benefit of Transrectal Saturation Prostate Biopsy as an Initial Biopsy Strategy: Decreased Likelihood of Finding Significant Cancer on Future Biopsy. Urology. 83(4). 714–718. 6 indexed citations
17.
Li, Xiangdong, Shengjie Guo, Zhiming Wu, et al.. (2014). Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors. World Journal of Urology. 33(9). 1351–1357. 11 indexed citations
18.
19.
Liu, Jianye, Yonghong Li, Zhiling Zhang, et al.. (2013). Influence of body mass index on oncological outcomes in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. International Journal of Urology. 21(2). 136–142. 15 indexed citations
20.
Li, Yonghong, Yiji Liao, Shi‐Juan Mai, et al.. (2013). High Expression of H3K27me3 Is an Independent Predictor of Worse Outcome in Patients with Urothelial Carcinoma of Bladder Treated with Radical Cystectomy. BioMed Research International. 2013. 1–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milan Vošmik Breakdown of academic impact, for papers by Priya Kumar Breakdown of academic impact, for papers by Mariana M. Cajaiba Breakdown of academic impact, for papers by Isabel Trias Breakdown of academic impact, for papers by Andrea Ambrosini‐Spaltro Breakdown of academic impact, for papers by Markus Falk Breakdown of academic impact, for papers by H Sugao Breakdown of academic impact, for papers by Riley E. Alexander Breakdown of academic impact, for papers by Giada Maria Vecchio Breakdown of academic impact, for papers by T. Geldart
Rankless by CCL
2026